The Weekly Litigation News Digest is now live. Subscribe now

Imba Institut Fr Molekulare Biotechnologie competitive analysis

Loading summary...

Explore Imba Institut Fr Molekulare Biotechnologie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Aug 21, 2024Heart Tissue Model1
May 2, 2018Breast Cancer Therapeutics2

Latest PTAB cases involving Imba Institut Fr Molekulare Biotechnologie

Discover the latest PTAB cases involving Imba Institut Fr Molekulare Biotechnologie, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Imba Institut Fr Molekulare Biotechnologie with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IMBA INSTITUT FR MOLEKULARE BIOTECHNOLOGIE - 3 - -
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBB11 - - -
GENOME BIOLOGICS1 - - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - -